Jasmanda H. Wu

Statistics

Publications

Citations

H-Index

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Jasmanda H. Wu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, pharmaceutical policy, and patient-reported outcome measures.

ORCID

Publications per year

2006–2016

Publications

The US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy (REMS) Program – Current Status and Future Direction

Jasmanda H. Wu, Juhaeri Juhaeri · Clinical Therapeutics · 2016 · 29 citations

Pharmacy, Pharmaceutical Policy, Risk Management +15

Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort

Jasmanda H. Wu, David H. Howard, John E. McGowan et al. · Clinical Therapeutics · 2006 · 25 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: A secondary analysis of a randomized, double-blind, placebo-controlled trial

Gahan Pandina, Dennis A. Revicki, Leah Kleinman et al. · Journal of Affective Disorders · 2009 · 13 citations · Full text

Social Sciences, Psychiatry, Psychology +17

1–3 of 3